SPRY R&D to Revenue
Ars Pharmaceuticals Inc · R&D to Revenue
SPRY R&D to Revenue
Latest reported15.64%period ending
SPRY FY R&D/Revenue (0.00% → 15.64%)
Latest values, visible window
High-resolution chart · PNG
SPRY r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.6399% | |
| 21.9632% | |
| 67,553.3333% | |
| 1,396.3526% | |
| 368.1983% | |
| 78.8898% | |
| 0% | |
| 0% |